@article {1182, title = {Analysis of GABRB3 Protein Level After Administration of Valerian Extract (Valeriana officinalis) in BALB/c mice}, journal = {Pharmacognosy Journal}, volume = {12}, year = {2020}, month = {June 2020}, pages = {821-827}, type = {Research Article}, chapter = {821}, abstract = {

Background: Valeriana officinalis is most commonly used as traditional medicine. Valerenic acid is the primary component of Valerian officinalis which inhibits the catabolism of enzyme induced breakdown of gamma amino butyric acid (GABA) in the brain, resulting in sedation. The aim of this study is to determine the level of GABRB3 protein, as part of major inhibitory neurotransmitter in the brain, after administration of Valerian extracts in BALB/c mice. Materials and Methods: This is an experimental study using animal model with post test-only controlled group design. Twenty healthy adult male BALB/c mice were randomly divided into four groups, negative control group (Aquadest), positive control group (Diazepam 0.025 mg/10 g), first treatment group (Valerian extract 2.5 mg/10 g) and second treatment group (Valerian extract 5 mg/10 g). The drugs were administered via gastric gavage for seven consecutive days. The blood was drawn from each mice on the first day (before treatment) and on the seventh day of experiment (2 hours after treatment). The blood sample was examined by enzyme-linked immunosorbent assay (ELISA) to determine the GABRB3 protein level. Results: GABRB3 protein level in BALB/c mice after administration of Valerian extract was increased significantly in both treatment group (p \<0.0001). The highest increment in protein levels was found in the first treatment group with an increase of 2.988 μmol/L, compared with the second treatment group with an increase of 2.146 μmol/L. Conclusion: GABRB3 protein level in BALB/c mice were increased after administration of Valerian extract. Administration of higher dose does not yield in higher GABRB3 protein level nor sedative effect.

}, keywords = {BALB/c mice, Diazepam, GABRB3 protein, Valerian extract}, doi = {10.5530/pj.2020.12.118}, author = {Erwin Mulyawan and Muhammad Ramli Ahmad and Andi Asadul Islam and Muh Nasrum Massi and Mochammad Hatta and Syafri Kamsul Arif} } @article {611, title = {Bombax ceiba: A Potential Anti-Anxiety Drug}, journal = {Pharmacognosy Journal}, volume = {10}, year = {2018}, month = {May 2018}, pages = {712-714}, type = {Research Article}, chapter = {712}, abstract = {

Background: Bombax ceiba is a famous plant used extensively in traditional medicine for various diseases. However, data pertaining to its effects at CNS level is limited. Objective: To analyze the anti-anxiety potential of ethanolic extracts of Bombax ceiba leaves on rats using the elevated plus maze protocol. Materials and Methods: Five groups containing six rats each were treated with respective drugs.Control rats were treated with 0.5ml of 10\% ethanol i.p. (negative control). Single treatments of diazepam (2mg/kg i.p) were used as a positive control and varied levels of ethanolic extracts of Bombax ceiba leaves (150 mg/kg, 250 mg/kg, 400 mg/kg, i.p.) were applied to other groups. The index of anxiety was measured by observing the entry and time duration in the open arm of the EPM. Results: Extract at 400 mg/kg significantly increased the time duration and number of entries into the open arm which was statistically significant (p value \<0.05) when compared to the control group (ethanol). Diazepam showed the most significant results when compared to other groups (p\<0.0005). Extracts at 150 mg/kg and 250 mg/kg demonstrated negligible results that were statistically insignificant. Conclusion: The results indicate the anti-anxiety potential of Bombax ceiba leaves at higher concentration. Further studies are required to analyze the implicated phytochemicals and the mechanism at cellular level.

}, keywords = {Anti-anxiety, Bombax ceiba leaves, Diazepam, Elevated Plus Maze, Ethanol}, doi = {10.5530/pj.2018.4.118}, url = {http://fulltxt.org/article/656}, author = {Abdulrahman Alsayari and Mohammed Ghazwani and Dalia Almaghaslah and Yahya Alhamhoom and Maha Saad and Rawan Ahmed and Wafa Saeed and Wijden Ali and Sadia Batool} }